Diabetes and Endocrinology Topic Homepage

Type 2 Diabetes

,Type 2 Diabetes CME and Knowledge Centre

Based on current estimates, the global prevalence of Type 2 diabetes mellitus has increased almost 10 fold since 1985 and is expected to rise to 552 million by 2030,1 and when absolute numbers of people with diabetes are considered, it is South East Asia and the West Pacific that are expected to experience the highest increases in prevalence over the coming years.2

An EACCME accredited CME is available, awarded 1 European CME credits (ECMEC's). Consisting of 3 modules:

  • A Review of Newer Therapies for Type 2 Diabetes in Combination with Insulin, John Wilding (Chair)
  • Identifying and Managing the Psychosocial Aspects of Type 2 Diabetes Mellitus, Richard Holt (Faculty)
  • Potential Role of Newer Therapies for Type 2 Diabetes in Combination with Insulin: Interactive Case Discussion, Bernard Charbonnel (Faculty)

Take CME now

The Type 2 Diabetes Knowledge Centre aims to provide clear and concise information based on current accepted guidelines on the treatment and management of patients with this disease. In addition the Knowledge Centre also provides access to key guidelines and a review of treatment options available.

Visit Knowledge Centre 


References

  1. Murea M, Ma L, Freedman BI. Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complications. Rev Diabetic Studies 2012;9:6-22.
  2. International Diabetes Federation. Diabetes atlas: second edition. 2002. Available at: www.idf.org/sites/default/files/IDF_Diabetes_Atlas_2ndEd.pdf (accessed 18 November 2013).

 

Obesity CME

,Understanding Obesity CME

In this accredited CME activity*, you will learn about obesity as a serious medical disease, including comorbidities and complications; the complex factors that influence its development; and the cornerstones of an effective weight management strategy.

After completion of this activity, healthcare professionals (endocrinologists, obesity specialists, primary care physicians and specialist nurses) should be able to:

  • explain why obesity is a serious medical disease
  • discuss how diet and physical activity are key determinants of obesity
  • provide an overview of clinical guideline recommendations for obesity management
  • assess the different approaches for achieving successful weight loss in obese individuals

*The European Obesity Initiative eCME module – Understanding Obesity, organised by apothecom as part of an unrestricted educational grant from Novo Nordisk, is awarded 2 European CME credits (ECMEC's).

Men's Health

Men's Health

The Men’s Health Knowledge Centre is a resource for healthcare professionals contains a latest updates section with monthly editorials of recently published articles in the area of hypogonadism (low testosterone), and the effect this hormone deficiency has on has on hypogonal men. This clear and concise information concerning this endocrine disorder makes this resource essential regular viewing for endocrinologists.

In addition to this reguarally updated content, sections detailing the diagnosis, treatment and monitoring of men with erectile dysfunction (ED) or hypogonadism (low testosterone) are also available. This extensive resource aims to provide endocrinologists and other healthcare professionals with a better understanding of the epidemiology and etiology of these diseases and provide information about available treatment options for these men.

Medical Videos

An Overview of Pancreatic NET and the Available Treatments
An Overview of Pancreatic NET and the Available Treatments
Ann T. Sweeney, MD, discusses the efficacy of team-managed insulin initiation compared with a standard approach in patients with type 2 diabetes.
Ann T. Sweeney, MD, discusses the efficacy of team-managed insulin initiation compared with a standard approach in patients with type 2 diabetes.
Diabetic Macular Edema
Diabetic Macular Edema
Type 2 Diabetes - Professor Edwin Gale discusses achievements in diabetes research and the theory around category error.
Type 2 Diabetes - Professor Edwin Gale discusses achievements in diabetes research and the theory around category error.
ADA/EASD Consensus Algorithm for the Treatment of Diabetes Mellitus
ADA/EASD Consensus Algorithm for the Treatment of Diabetes Mellitus
Peter Attia: What if we're wrong about diabetes?
Peter Attia: What if we're wrong about diabetes?
The Cause of Obesity
The Cause of Obesity
Diuretics, b-blockers, and statins in increasing the risk of type 2 diabetes
Diuretics, b-blockers, and statins in increasing the risk of type 2 diabetes
From the Monster's Mouth - A BMJ Investigation into the effects of Type 2 Diabetes Treatments on the Pancreas
From the Monster's Mouth - A BMJ Investigation into the effects of Type 2 Diabetes Treatments on the Pancreas

Recent Drug Updates

Medical Journal Abstracts on Diabetes and Endocrinology

Long-term Effects of Therapy with Ranibizumab on Diabetic Retinopathy Severity and Baseline Risk Factors for Worsening Retinopathy

8 days ago -  Ophthalmology

Purpose: To assess the effects of intravitreal ranibizumab on diabetic retinopathy (DR) severity when administered for up to 3 years, evaluate the effect of delayed initiation of ranibizumab ...

Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events, and incident cancer

Fri 14 Nov 2014 -  Diabetes, Obesity and Metabolism

Aims: To evaluate the association between insulin exposure and all-cause mortality, incident major adverse cardiovascular events (MACE), and incident cancer in people with type 2 diabetes treated ...

Clinical Guidelines

Type 2 diabetes: The management of type 2 diabetes

Jul 2014

This guideline offers best practice advice on the care of people with type 2 diabetes. It does not..

... address care in or before pregnancy, or care by specialist services for specific advanced organ damage (cardiac, renal, eye, vascular, stroke and other services).

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

Oct 2013

The emphasis in these Guidelines is to provide information on the current state of the art in how to..

... prevent and manage the diverse problems associated with the effects of DM (Diabetes Mellitus) on the heart and vasculature in a holistic manner. In describing the mechanisms of disease,we hope to provide an educational tool and, in describing the latest management approaches, an algorithm for achieving the best care for patients in an individualized setting. It should be noted that these guidelines are written for the management of the combination of CVD (or risk of CVD) and DM, not as a separate guideline for each condition.

Online CME

Obesity Management Today: Elevating Care via New Therapeutic Options

This activity is intended for primary care physicians, endocrinologists, nurses, obstetricians, gynecologists, and other allied healthcare professionals. The goal of this activity is to discuss 2 barriers to obesity treatment:...

Hyperthyroidism

This activity provides an overview of the main causes of hyperthyroidism and includes recommendations about which patients to screen and on the choices of treatment.

Hypoglycaemia learning programme - Fear of hypoglycaemia

This video, part of the four-module Hypoglycaemia learning programme, describes the fear of hypoglycaemia that patients have and its impact on the management of diabetes from a specialist, GP and...

Clinical Trials

A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms (DUAL™ VI)

19-11-2014

This trial is conducted in Europe, North America and the United States of America.

The aim of this trial is to compare two different titration algorithms of insulin degludec/liraglutide.

..

...

Effect of Soft Fruit on Postprandial Blood Glucose

11-11-2014

Dietary strategies for alleviating health complications associated with type 2 diabetes (T2D) are being pursued as alternatives to pharmaceutical interventions. Berries such as blackcurrants that are rich in polyphenols may influence carbohydrate..

... digestion and absorption and thus postprandial glycaemia. In addition berries have been reported to alter incretins as well as to have anti-oxidant and anti-inflammatory properties that may also affect postprandial glycaemia. This study investigated the acute affect blackcurrants on glucose metabolism in overweight/obese volunteers .

Back to top